MedWatch

CHMP approves 13 new drugs

During its monthly December meeting, the European Medicines Agency's (EMA) special committee, the CHMP, has recommended 13 drugs for approval and rejected one – an additional six drugs have received the green light to expand indications.

Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750

A string of new treatments has received the go-ahead from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs